DoW Peer Reviewed Medical, Technology/Therapeutic Development Award
Can you apply?
This grant is for organizations conducting translational medical research on military and Veteran health priorities. Applicants must have an established proof-of-concept or prototype ready to advance through final preclinical development stages. The research must target a congressionally directed FY26 topic area and align with FY26 strategic goals. Deliverables include a regulatory filing or clinical practice translation within the 4-year performance period.
This grant is for organizations conducting translational medical research on military and Veteran health priorities. Applicants must have an established proof-of-concept or prototype ready to advance through final preclinical development stages. The research must target a congressionally directed FY26 topic area and align with FY26 strategic goals. Deliverables include a regulatory filing or clinical practice translation within the 4-year performance period.
Program description
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award, a product-driven award mechanism, intends to support the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP strategic goals. Products can be tangible items, such as drugs or devices, or can be knowledge products, such as clinical decision-making tools or practice guidelines. Products in development should address or have dual purpose potential for the health care needs of military Service Members, Veterans and their Families.
Distinctive Features: For the PRMRP Technology/Therapeutic Development Award, the program expects the research proposed will take an already established proof-of-concept or prototype through the final stages of preclinical development. The PRMRP also expects that the research outcome will be a regulatory filing or translation of findings into clinical practice, as applicable.
Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $67.2M to fund approximately 12 Technology/Therapeutic Development Award applications with total cost caps of $5.6M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Who can apply
Eligible applicants
Demographic focus
Details
This grant is for organizations conducting translational medical research on military and Veteran health priorities. Applicants must have an established proof-of-concept or prototype ready to advance through final preclinical development stages. The research must target a congressionally directed FY26 topic area and align with FY26 strategic goals. Deliverables include a regulatory filing or clinical practice translation within the 4-year performance period.
How to apply
Application links
Required documents
- SF-424 (Federal Application for Grants and Cooperative Agreements)
- Project Narrative with regulatory/translation pathway
- Budget and Budget Justification
- Proof-of-concept or prototype documentation
- Institutional Certifications and Assurances
- Letters of Support from clinical or regulatory partners
Program contact
- 👤 Christopher L Baker Grants Officer
- 📧 help@eBRAP.org
- 📞 3016192332
Funding track record
Recent awards under CFDA 12.420 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$2,265,729,366
-
$800,631,761
-
$74,531,880
-
$67,205,571
-
$53,718,832
-
$34,191,124
-
$24,907,742
-
$21,394,379
-
$19,100,256
-
$19,002,641
Top States by Funding
- MD 10 awards $3,150.1M
- NC 11 awards $132.3M
- FL 8 awards $99.8M
- CA 11 awards $99.3M
- MA 7 awards $75.2M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 12.420). How funding has trended year over year.
| 2024 | $1,483,968,520 | |
| 2025 | $1,201,153,417 |
FAQ
Who can apply for this award?
Organizations with established proof-of-concept or prototype research are eligible. Contact your grants office to confirm your institution type meets Army eligibility requirements.
What types of products are funded?
Both tangible products (drugs, devices) and knowledge products (clinical tools, guidelines) are supported. Products must address health needs of Service Members, Veterans, or their families.
What is the deadline and funding timeline?
The application deadline is August 6, 2026. Awards will be made by September 30, 2027, using FY26 funds that expire September 30, 2032.
How much can I request?
Approximately 12 awards will be funded with total costs capped at $5.6 million per award. The maximum project duration is 4 years.
What outcome is expected?
The research must result in a regulatory filing or translation of findings into clinical practice. This is a product-driven mechanism focused on moving prototypes forward.
💡 Tips for applicants
- Start with your proof-of-concept or prototype documentation ready. This award expects mature early-stage work, not discovery-phase research.
- Align your project to a congressionally directed FY26 topic area and one of the FY26 PRMRP strategic goals. Review the full solicitation for current topic priorities.
- Build a realistic pathway to regulatory filing or clinical implementation. Reviewers want evidence of commercialization or clinical adoption plans.
- Address dual-use potential for both military and Veteran populations if possible. Products benefiting Service Members and Veterans together score stronger.
- Budget for the full translational pipeline. Include costs for final preclinical work, regulatory preparation, and early clinical strategy within your $5.6M cap.
⚠️ Common mistakes
Submitting early-stage discovery research instead of prototype-stage work. Reviewers expect proof-of-concept already validated. Failing to identify a specific FY26 congressionally directed topic. Review the solicitation's topic list before proposing a project. Unclear commercialization or clinical translation pathway. Be explicit about regulatory steps or practice adoption timeline.
Similar grants
- CLOSING SOON FY26 RFP PHTHOET26001 for EMS System Development and Sustainability Assessment — Iowa Department of Health and Human Services
- OPEN SFY2027 – Emergency Medical Services Grant Program — Montana Department of Transportation
- CLOSED 2023 AGR Potato Research and Market Development Program — Montana Department of Agriculture
- CLOSED 2022 AGR Potato Research and Market Development Program — Montana Department of Agriculture
- CLOSED 2021- AGR Potato Research and Market Development Program — Montana Department of Agriculture